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Objectives: To investigate the perception of Romanian hospital managers towards 
under financing of the health sector and to identify the major drawbacks on differ-
ent aspects of hospital activity. The Romanian hospitals are paid using DRG system 
since 2009. This is the first attempt to obtain an empiric imagine of the oppinoin of 
the hospital’s managers regarding the effect of inadequate financing and its con-
sequences. MethOds: In the last trimester of 2014, we have sent a questionnaire 
with 25 questions to the top management of every Romanian hospital. The quiz 
was based on the results of a focus group held in September 2014 which included 
7 managers from different hospitals in Romania. Results: In 2013 in Romania 
there were 435 hospitals contracting services with the social insurance system. 
The questionnaires were sent by mail and we received 82 answers, which were sent 
back by mail or completed anonymously in a special online application. 85% (70 of 
82) of the managers indicated that the budget negotiated with the social insurance 
system is insufficient and causes some to major difficulties, some of them saying 
that is impossible to cover their expenses. As a result, 34,3% of the underfinanced 
hospitals had difficulties in acquiring the medication for their patients! 22,8% of 
those said that they faced difficulties in buying the drugs that cost more than 22 
Euro per day of treatment. 94% of the managers believed that the official tariffs do 
not cover the expenses required by the services. cOnclusiOns: Under financing 
of the Romanian hospitals is due to the inadequate tariffs established unilateral 
by the National Insurance House. As a result, many of the hospitals are generating 
debts. As the wages are paid with priority, the main effect of under financing is an 
inadequate amount of money spent on drugs.
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Objectives: Isolate, Identify and Determine the Antimicrobial Resistance Pattern of 
Salmonella Speciesfrom Selected Poultry Farms in Debre Zeit, Ethiopia. MethOds: 
Cross sectional study was conducted to isolate, identify and determine antimicrobial 
susceptibility testing of salmonella organisms from four selected poultry farms in 
Debre Zeit, Ethiopia. A total of 196 chickens were sampled from four purposively 
selected commercial poultry farms. Cloacal swab samples were collected from 
live chickens using sterile cotton tipped swabs moistened with buffered peptone 
water. The swabs were kept in properly plugged sterile test tubes. Then Isolation 
and Identification of Salmonella,Biochemical Confirmation, Polymerase Chain 
Reaction (PCR) and Antimicrobial susceptibility testing were conducted. Results: 
From a total of 196 cloacal swabs collected 50 (25.5%) were found to be positive for 
Salmonella organisms using culture method, and 15 (7.6%) Salmonella isolates were 
confirmed using biochemical tests. All culture and biochemical positive samples 
were further confirmed by Polymerase Chain Reaction (PCR) through amplifica-
tion of histidine transport operon as a target gene for the presence of salmonella 
isolates. From culture and biochemical positive samples, gel electrophoresis of the 
PCR product revealed the presence of 496bp segments in 13 (6.7%) Salmonella iso-
lates. The statistical analysis has revealed a significantly association between dif-
ferent age groups of chickens (X2 = 10.56; P = 0.005) and farms (X2 = 10.74; P= 0.013) 
with the percentage of Salmonella isolates. Most of the Salmonella isolates were 
found to be resistant against commonly used antimicrobials such as Sulfisoxazole, 
Chloramphenicol and Ampicillin followed by Tetracycline, Amoxicillin/Clavulanic 
acid and Cephalotin and more than half(69.3%) of the isolates were found to be 
multi-drug resistant. cOnclusiOns: The high prevalence of resistance to antimi-
crobial agents found in this study might be attributed to uncontrolled use of anti-
microbial agents as growth promoters in poultry farms. Therefore, proper treatment 
of chickens using appropriate antibiotics is then quite essential.
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Objectives: Regulators and Health Technology Assessment (HTA)/Payer stake-
holders are increasingly looking into Real Word Evidence (RWE) for RE and BR. 
Demonstrating quality, efficacy and safety plus cost effectiveness (‘4thhurdle’) is 
no longer sufficient to ensure market authorization and reimbursement. While 
some RWE stakeholders require randomized study approaches, e.g. to avoid allo-
cation bias, typically in the form of ‘pragmatic’ trials, others consider observa-
tional studies or accept indirect comparisons in the absence of head-to-head 
comparison results. However, it is unknown how frequently respective compara-
tive approaches are actually used. MethOds: To assess relative importance of 
observational, pragmatic and indirect methodologies for comparative RE and BR, 
we surveyed Medline using purpose related terms ‘relative/comparative effective-
ness’ or ‘benefit/risk’ in combination with methodology terms ‘observational/
non-interventional’, ‘pragmatic study/trial’, and ‘indirect comparison/network 
analysis’. Resulting publication numbers were analyzed, and selected abstracts 
were assessed qualitatively. Results: We focused on publication title analysis as 
all field searches yielded heterogenous results. Publication title hits were by far 
highest for OBS methodologies, followed by PRA and lowest for IND (13,247; 201; 
141), and higher for BR than for CE (3,017; 1,152). RE publications continuously 
increased over time with not more than 50 annual hits before 2005, but consist-
ently above 250 hits after 2013. Similarly, annual CE hits were below 20 before 2006, 
increased to 250 as of 2010, but tended to decrease after a peak in 2013. For RE, OBS 
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Objectives: The objective of this study was to analyze the implementation 
process and changes over a 4-year period of medication review services in an 
older adult population in German community pharmacies. Medication review 
is a patient-oriented service, designed to identify drug-related problems in a 
personal consultation. MethOds: This study focuses on adults older than 65 
years. Medication reviews were conducted in 254 pharmacies in Germany and 
analyzed over a 4-year period (2011 to 2014). Data extracted from medication 
reviews included patient demographics, drug-related problems (DRPs) detected 
by the pharmacy and pharmacy-related data. In addition to descriptive analysis, 
we performed binary multivariate logistic regression models to identify the main 
patient-, medication- and pharmacy-related predictors associated with the over-
all assessment of therapy. Results: A total of 2,931 medication reviews were 
analyzed with patients aged between 66 and 98 years. In the sample, the mean 
number of medicines taken by individuals was 6.08 with 66.6% of individuals tak-
ing five or more medicines. During the 4-year period, in 60.5% of all medication 
reviews (n = 2,931), DRPs were detected by participating pharmacies; significant 
differences could be determined between different years (p< 0.001) with scores 
ranging from 56.7% to 66.7%. In nearly half (47.1%) of the medication reviews, 
interactions were detected and the interaction potential was classified according 
to the ABDA database classification system. However, over-supply remains low 
at 6.9% of all medication reviews. Binary multivariate logistic regression analysis 
revealed different significant patient- and pharmacy-related predictors associ-
ated with overall assessment of therapy. cOnclusiOns: Findings indicate the 
potential to identify drug-related problems through medication review, based on 
a disclosure of all drugs taken by the patient. The extent of implementation of 
medication review in Germany cannot be regarded as satisfying at present. Hence, 
existing programs should be enhanced to increase the number of participating 
pharmacies and patients.
PHP161
can graPeFruit juice make SaFe DrugS unSaFe or ineFFective? an 
eviDence-baSeD anSwer
Quignot N1, Amzal B2
1LASER Analytica, Paris, France, 2LASER Analytica, London, UK
Objectives: Grapefruit juice is known for its ability to interact with the phar-
macokinetics of many drugs. This work aims at characterising and synthesizing 
evidence on this interaction via systematic reviews and modelling. MethOds: 
Systematic review was performed to collect data on metabolic interactions 
between 35 drugs metabolized via the CYP3A4 metabolic pathway and grape-
fruit juice. Magnitude of interaction was defined as the ratio of areas under the 
curve with and without grapefruit juice. A Bayesian hierarchical meta-analysis 
model was used to quantify such interactions and the chemical-specific inter-
individual variability. Impact of real-world metabolic interactions on benefit 
risks on drugs was discussed. Results: Data from more than two hundred 
studies were collected, involving 35 widely used drugs. Grapefruit juice property 
to inhibit the CYP3A4 elimination translated into up to 20-fold higher internal 
doses hence raising potential safety concerns. Statistically significant magni-
tudes of pharmacokinetic effect ranged from 1.09 to 22.07. The mean magnitude 
of (CYP3A4-specific) interaction was estimated at 3.73 (95%-credibility interval 
[0.76-23.14]). cOnclusiOns: This work illustrates how real-life food-drug inter-
actions can severely impact real-world benefit/risk of drugs. Such information 
may be accounted for to inform risk management plans and to optimize early 
drug development.
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Objectives: Population aging has brought greater demand for admissions of 
patients with chronic diseases fleeing the routine therapeutic goals. The objec-
tive of this study is to evaluate the application of Karnofsky Performance Scale 
(KPS) to identify patients who need palliative care and avoiding therapeutic futil-
ity. MethOds: An observational vertical prevalence study made in June 2014 of 
clinical patients admitted in a public hospital in São Paulo city, by applying a brief 
and objective questionnaire directly to patient’s physicians in order to obtain a 
diagnosis of the clinical situation aspects, based on KPS. Results: According to the 
analyze of 259 questionnaires/patients (Female: 111 and male: 148) from all adult 
inpatient sectors in the hospital (medical wards, surgical wards and intensive care 
unit), we found: a) 62.55% with KPS ≥ 50 (without advanced disease); b) 2.70% with 
KPS = 40 (disease in progression to advanced); c) 1.16% with KPS = 30 (advanced 
disease, with no expectation of cure, unless performing organ transplants); d) 15.44% 
with KPS = 20 (advanced disease without an effective cure or treatment that can 
modifies the disease); e) 17.76% with KPS = 10 (death prediction in the present 
admission). Only one patient could not be classified. About 57% of patients were 
older than 50 years. cOnclusiOns: The KPS analysis showed 37.45% of the patients 
were with advanced disease condition and without possibility of cure who should 
be better treated in palliative care environments with more specific conditions 
for them, without using numerous and expensive drugs and procedures which 
only cause more suffering to these group of patients. To disseminate and applying 
the knowledge in palliative care will certainly contribute to a more rational use of 
therapeutic resources.
